Similar to this, in an ALK-resistant ALK+ ALCL patient whose tumor tissue highly expresses PD-L1, the tumor tissue completely disappeared after 5 months of Navumab treatment and the complete remission was maintained for up to 18 months (149). Here, CD274 is linked to anaplastic large cell lymphoma.